High-flying Kite could score big with new cancer treatment
Kite Pharma, one of the hottest biotech start-ups on Wall Street, hopes to revolutionize the treatment of a common, deadly lymphatic cancer — with a novel mix of highly trained lab techs and high-speed air travel.
The Santa Monica company's treatment of non-Hodgkin's lymphoma reprograms a patient's...